188 related articles for article (PubMed ID: 6747842)
21. Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera.
Galán JA; Sánchez EE; Rodríguez-Acosta A; Pérez JC
Toxicon; 2004 Jun; 43(7):791-9. PubMed ID: 15284013
[TBL] [Abstract][Full Text] [Related]
22. Anti-platelet effect of cumanastatin 1, a disintegrin isolated from venom of South American Crotalus rattlesnake.
Da Silva M; Lucena S; Aguilar I; Rodríguez-Acosta A; Salazar AM; Sánchez EE; Girón ME; Carvajal Z; Arocha-Piñango CL; Guerrero B
Thromb Res; 2009 Mar; 123(5):731-9. PubMed ID: 18835011
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the biological and immunological properties of fractions of prairie rattlesnake (Crotalus viridis viridis) venom.
Ownby CL; Colberg TR
Toxicon; 1987; 25(12):1329-42. PubMed ID: 3125631
[TBL] [Abstract][Full Text] [Related]
24. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications.
Saravia P; Rojas E; Arce V; Guevara C; López JC; Chaves E; Velásquez R; Rojas G; Gutiérrez JM
Rev Biol Trop; 2002 Mar; 50(1):337-46. PubMed ID: 12298262
[TBL] [Abstract][Full Text] [Related]
25. Complement inactivating proteins and intraspecies venom variation in Crotalus oreganus helleri.
Jurado JD; Rael ED; Lieb CS; Nakayasu E; Hayes WK; Bush SP; Ross JA
Toxicon; 2007 Mar; 49(3):339-50. PubMed ID: 17134729
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular alterations induced by the venom of Lachesis muta (serpentes: Viperidae) and its fibrinogenolitic enzyme].
Granados-Zúñiga J; Aragón-Ortíz F
Rev Biol Trop; 1998 Dec; 46(4):1149-57. PubMed ID: 10751938
[TBL] [Abstract][Full Text] [Related]
27. Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization.
French WJ; Hayes WK; Bush SP; Cardwell MD; Bader JO; Rael ED
Toxicon; 2004 Dec; 44(7):781-91. PubMed ID: 15500854
[TBL] [Abstract][Full Text] [Related]
28. The improvement of the therapeutic anti-Lachesis muta serum production in horses.
Stephano MA; Guidolin R; Higashi HG; Tambourgi DV; Sant'Anna OA
Toxicon; 2005 Mar; 45(4):467-73. PubMed ID: 15733568
[TBL] [Abstract][Full Text] [Related]
29. Disseminated intravascular coagulation following Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
Schaeffer RC; Briston C; Chilton SM; Carlson RW
J Lab Clin Med; 1986 Jun; 107(6):488-97. PubMed ID: 3086470
[TBL] [Abstract][Full Text] [Related]
30. Isolation, stabilization, and characterization of a toxin from timber rattlesnake venom.
Sullivan J; Geren CR
Prep Biochem; 1979; 9(3):321-33. PubMed ID: 471946
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
Monteiro RQ; Zingali RB
Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
[TBL] [Abstract][Full Text] [Related]
32. The effect of Echis carinatus crude venom and purified protein fractions on carbohydrate metabolism in rats.
Al-Saleh SS
Cell Biochem Funct; 2002 Mar; 20(1):1-10. PubMed ID: 11835265
[TBL] [Abstract][Full Text] [Related]
33. Effects of the venom of the Southern Pacific rattlesnake, Crotalus viridis helleri, and its fractions on striated and smooth muscle.
Metsch RB; Dray A; Russell FE
Proc West Pharmacol Soc; 1984; 27():395-8. PubMed ID: 6494179
[No Abstract] [Full Text] [Related]
34. Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom.
Ouyang C; Yang FY
Biochim Biophys Acta; 1975 Apr; 386(2):479-92. PubMed ID: 1138881
[TBL] [Abstract][Full Text] [Related]
35. [Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma].
Mischke R; Wohlsein P; Busse L; Pohlenz J
Schweiz Arch Tierheilkd; 1998; 140(12):497-505. PubMed ID: 9863356
[TBL] [Abstract][Full Text] [Related]
36. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular failure produced by a peptide from the venom of the southern Pacific rattlesnake, Crotalus viridis helleri.
Schaeffer RC; Pattabhiraman TR; Carlson RW; Russell FE; Weil MH
Toxicon; 1979; 17(5):447-53. PubMed ID: 42172
[No Abstract] [Full Text] [Related]
39. [Effect of Tityus discrepans scorpion venom on global coagulation test. Preliminary studies].
Brazón J; Guerrero B; Arocha-Piñango CL; Sevcik C; D'Suze G
Invest Clin; 2008 Mar; 49(1):49-58. PubMed ID: 18524331
[TBL] [Abstract][Full Text] [Related]
40. Isolation of myotoxic component from rattlesnake (Crotalus viridis viridis) venom. Electron microscopic analysis of muscle damage.
Ownby CL; Cameron D; Tu AT
Am J Pathol; 1976 Oct; 85(1):149-66. PubMed ID: 970437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
